UPDATED Apr 22, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$407.06 | -1.8% | 47.8% | US$3.0t | US$471.24 | PE36.6x | E12.6% | 0.7% | Software | ||
GOOGL | US$158.27 | 2.5% | 52.4% | US$2.0t | US$166.83 | PE26.7x | E11.8% | n/a | Media | ||
AMZN | US$179.52 | -2.1% | 75.0% | US$1.8t | US$209.79 | PE61.4x | E21.6% | n/a | Retail | ||
META | US$495.78 | -0.8% | 138.9% | US$1.2t | US$541.20 | PE32.2x | E14.4% | 0.4% | Media | ||
LLY | US$745.69 | -0.1% | 93.8% | US$658.8b | US$813.32 | PE128.2x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$754.00 | -4.3% | 51.4% | NT$19.6t | NT$912.98 | PE22.8x | E16.1% | 1.9% | Semiconductors | ||
AVGO | US$1,248.70 | -6.0% | 100.7% | US$567.4b | US$1,500.96 | PE50x | E23.4% | 1.7% | Semiconductors | ||
NOVO B | kr.891.30 | 2.7% | 54.4% | kr.3.9t | kr.904.20 | PE47.5x | E14.8% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$192.14 | 6.3% | 39.6% | US$544.0b | US$205.53 | PB1.8x | E-1.7% | 2.4% | Banks | ||
WMT | US$59.09 | -1.3% | 17.0% | US$484.6b | US$65.08 | PE30.7x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$121.03 | 2.0% | 3.9% | US$477.2b | US$129.81 | PE13.3x | E-0.6% | 3.1% | Energy | ||
UNH | US$486.18 | 3.7% | -1.2% | US$452.0b | US$568.86 | PE29.1x | E19.7% | 1.5% | Healthcare | ||
700 | HK$332.40 | 10.1% | -1.8% | HK$3.1t | HK$417.87 | PE24.8x | E15.0% | 1.0% | Media | ||
PG | US$161.50 | 3.6% | 3.3% | US$378.9b | US$169.90 | PE25.7x | E6.8% | 2.3% | Household | ||
A005930 | ₩75,500.00 | -5.6% | 18.7% | ₩503.0t | ₩101,991.89 | PE35.4x | E27.4% | 1.9% | Tech | ||
JNJ | US$149.56 | 3.5% | -9.5% | US$359.3b | US$173.60 | PE18.8x | E5.1% | 3.3% | Pharmaceuticals & Biotech | ||
HD | US$339.00 | 1.2% | 14.4% | US$333.1b | US$384.83 | PE22.2x | E4.2% | 2.7% | Retail | ||
MRK | US$126.88 | 1.5% | 8.9% | US$321.5b | US$137.58 | PE880.5x | E25.9% | 2.4% | Pharmaceuticals & Biotech | ||
COST | US$722.68 | 0.9% | 43.6% | US$317.3b | US$776.41 | PE47.2x | E7.5% | 0.6% | Consumer Retailing | ||
ORCL | US$115.09 | -4.6% | 22.4% | US$314.8b | US$137.02 | PE29.7x | E14.7% | 1.4% | Software | ||
CVX | US$162.85 | 4.2% | -3.6% | US$299.1b | US$181.37 | PE14.1x | E2.3% | 4.0% | Energy | ||
ABBV | US$169.54 | 4.3% | 2.8% | US$297.3b | US$184.14 | PE62.3x | E23.4% | 3.7% | Pharmaceuticals & Biotech | ||
BAC | US$38.37 | 10.6% | 33.0% | US$296.8b | US$39.52 | PB1.1x | E6.2% | 2.5% | Banks | ||
600519 | CN¥1,692.28 | 1.3% | -2.2% | CN¥2.1t | CN¥2,154.31 | PE28.4x | E12.8% | 3.0% | Food, Beverage & Tobacco |